FDA approves Cobenfy, the first schizophrenia drug in 30 yearsSeptember 29, 2024 The FDA has approved Cobenfy, the first new schizophrenia medication in over 30 years, offering a novel treatment approach for managing symptoms like hallucinations and delusions.